PUBLISHER: The Business Research Company | PRODUCT CODE: 1720750
PUBLISHER: The Business Research Company | PRODUCT CODE: 1720750
Cholestatic Pruritus Global Market Report 2025
Cholestatic pruritus is a condition characterized by severe itching due to the accumulation of bile acids in the skin, often caused by liver diseases that hinder bile flow. This condition can greatly impact a patient's quality of life and typically requires targeted treatments to alleviate discomfort and address the underlying liver dysfunction.
The primary disease types associated with cholestatic pruritus include primary biliary cholangitis (PBC), primary sclerosing cholangitis (PSC), intrahepatic cholestasis of pregnancy (ICP), and other related conditions. Primary biliary cholangitis (PBC) is a chronic autoimmune liver disease that progressively destroys the bile ducts, causing bile accumulation, liver damage, and possibly cirrhosis. Treatment options for cholestatic pruritus include medications, phototherapy, and other treatments, with administration routes such as oral, topical, and injectable forms. The key end-users for these treatments include hospitals, clinics, ambulatory care centers, and home care settings.
The cholestatic pruritus market research report is one of a series of new reports from The Business Research Company that provides cholestatic pruritus market statistics, including the cholestatic pruritus industry global market size, regional shares, competitors with the cholestatic pruritus market share, detailed cholestatic pruritus market segments, market trends, and opportunities, and any further data you may need to thrive in the cholestatic pruritus industry. This cholestatic pruritus market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.
The cholestatic pruritus market size has grown strongly in recent years. It will grow from $19.20 billion in 2024 to $20.28 billion in 2025 at a compound annual growth rate (CAGR) of 5.6%. The growth during the historic period can be attributed to the increasing prevalence of skin disorders, higher investments in research and development, growing demand for effective treatments, greater awareness of the condition, and favorable regulatory environments.
The cholestatic pruritus market size is expected to see strong growth in the next few years. It will grow to $24.97 billion in 2029 at a compound annual growth rate (CAGR) of 5.3%. The growth in the forecast period can be attributed to the rising elderly population, the increasing prevalence of atopic dermatitis and urticaria, a higher incidence of chronic kidney diseases, and the growing prevalence of conditions associated with pruritus. Key trends during this period include the introduction of new treatment options, partnerships with major companies for cholestatic pruritus research, innovations in treatment modalities, the expansion of healthcare facilities, and technological advancements in care.
The increasing prevalence of liver diseases is expected to drive the growth of the cholestatic pruritus market. Liver diseases encompass a wide range of conditions that impair liver function, including infections, autoimmune disorders, genetic conditions, and damage from toxins, all of which can lead to inflammation, scarring, or even liver failure. Factors such as rising obesity rates, diabetes, alcohol consumption, viral hepatitis, and exposure to environmental toxins contribute to the growing prevalence of liver diseases. Cholestatic pruritus is an important symptom for identifying and managing liver diseases, as it signals impaired bile flow and often prompts further investigation and treatment of underlying liver conditions. For example, in July 2023, the Office for Health Improvement and Disparities, a UK government agency focused on reducing health inequalities, reported that hospital admissions for liver disease in England had risen by 22% in the year ending 2022, from 67,458 to 82,290. The increasing incidence of liver diseases will thus drive the demand for treatments in the cholestatic pruritus market.
Major companies in the cholestatic pruritus market are focusing on developing innovative treatments, such as oral solutions, to better manage symptoms, improve patient compliance, and provide targeted relief by addressing the root causes of bile salt buildup and inflammation. Oral solutions for cholestatic pruritus are liquid medications designed to reduce bile acid accumulation and alleviate severe itching in patients with cholestasis. For instance, in March 2024, Mirum Pharmaceuticals Inc., a U.S.-based biopharmaceutical company, received approval from the U.S. Food and Drug Administration (FDA) for LIVMARLI (maralixibat) oral solution, which is used to treat cholestatic pruritus in patients aged five and older with progressive familial intrahepatic cholestasis (PFIC). This once-daily, orally administered medication is an ileal bile acid transporter inhibitor and has been designated as a breakthrough therapy for PFIC type 2. LIVMARLI offers a much-needed treatment option for patients with cholestatic pruritus linked to PFIC, particularly for those with the rarest subtypes.
In September 2023, Travere Therapeutics Inc., a U.S.-based biopharmaceutical company, entered into a partnership with Mirum Pharmaceuticals Inc. Through this collaboration, Travere will focus on its core therapeutic areas while Mirum continues to expand its portfolio and develop and commercialize bile acid therapies for rare liver diseases. Mirum Pharmaceuticals is dedicated to advancing treatments for rare liver diseases, including those associated with cholestatic pruritus.
Major players in the cholestatic pruritus market are GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Merck KGaA, Regeneron Pharmaceuticals Inc., Bausch Health Companies Inc., Incyte Corporation, Ipsen Pharma, Vanda Pharmaceuticals Inc., Medison Pharma Ltd., Mirum Pharmaceuticals Inc., Albireo Pharma Inc., Dipharma Francis S.r.l., Cara Therapeutics Inc., CANbridge Pharmaceuticals Inc., Escient Pharmaceuticals Inc., Tharimmune Inc., Vifor Fresenius Medical Care Renal Pharma, CymaBay Therapeutics Inc., ICE Pharma Inc., and Aquatic Remedies Private Limited.
North America was the largest region in the cholestatic pruritus market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in cholestatic pruritus report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the cholestatic pruritus market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The cholestatic pruritus market consists of revenues earned by entities by providing services such as diagnosis and screening services, medical consultations and treatment management, patient support programs, and counseling. The market value includes the value of related goods sold by the service provider or included within the service offering. The cholestatic pruritus market also includes sales of ursodeoxycholic acid, topical corticosteroids, and opioid antagonists. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Cholestatic Pruritus Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on cholestatic pruritus market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
- Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
- Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market shares.
- Benchmark performance against key competitors.
- Suitable for supporting your internal and external presentations with reliable high quality data and analysis
- Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for cholestatic pruritus ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The cholestatic pruritus market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
- Markets Covered:1) By Disease Type: Primary Biliary Cholangitis (PBC); Primary Sclerosing Cholangitis (PSC); Intrahepatic Cholestasis of Pregnancy (ICP); Other Disease Types
- 2) By Treatment Type: Medications; Phototherapy; Other Treatment Types
- 3) By Route Of Administration: Oral; Topical; Injectable
- 4) By End-User: Hospitals; Clinics; Ambulatory Care Centers; Homecare
- Subsegments:
- 1) By Primary Biliary Cholangitis (PBC): Early-Stage PBC; Advanced PBC; PBC With Cirrhosis; PBC With Liver Failure
- 2) By Primary Sclerosing Cholangitis (PSC): Classic PSC; PSC With Ulcerative Colitis; PSC With Bile Duct Strictures
- 3) By Intrahepatic Cholestasis of Pregnancy (ICP): Mild ICP; Severe ICP; ICP With Preterm Birth Risk
- 4) By Other Disease Types: Alcoholic Cholestasis; Drug-Induced Cholestasis; Viral Hepatitis-Induced Cholestasis; Genetic Cholestasis Disorders
- Companies Mentioned: GlaxoSmithKline plc; Takeda Pharmaceutical Company Limited; Merck KGaA; Regeneron Pharmaceuticals Inc.; Bausch Health Companies Inc.
- Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
- Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
- Time series: Five years historic and ten years forecast.
- Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
- Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
- Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
- Delivery format: PDF, Word and Excel Data Dashboard.
Table of Contents
1. Executive Summary
2. Cholestatic Pruritus Market Characteristics
3. Cholestatic Pruritus Market Trends And Strategies
4. Cholestatic Pruritus Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market
5. Global Cholestatic Pruritus Growth Analysis And Strategic Analysis Framework
- 5.1. Global Cholestatic Pruritus PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
- 5.2. Analysis Of End Use Industries
- 5.3. Global Cholestatic Pruritus Market Growth Rate Analysis
- 5.4. Global Cholestatic Pruritus Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
- 5.5. Global Cholestatic Pruritus Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
- 5.6. Global Cholestatic Pruritus Total Addressable Market (TAM)
6. Cholestatic Pruritus Market Segmentation
- 6.1. Global Cholestatic Pruritus Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Primary Biliary Cholangitis (PBC)
- Primary Sclerosing Cholangitis (PSC)
- Intrahepatic Cholestasis of Pregnancy (ICP)
- Other Disease Types
- 6.2. Global Cholestatic Pruritus Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Medications
- Phototherapy
- Other Treatment Types
- 6.3. Global Cholestatic Pruritus Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Oral
- Topical
- Injectable
- 6.4. Global Cholestatic Pruritus Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Hospitals
- Clinics
- Ambulatory Care Centers
- Homecare
- 6.5. Global Cholestatic Pruritus Market, Sub-Segmentation Of Primary Biliary Cholangitis (PBC), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Early-Stage PBC
- Advanced PBC
- PBC With Cirrhosis
- PBC With Liver Failure
- 6.6. Global Cholestatic Pruritus Market, Sub-Segmentation Of Primary Sclerosing Cholangitis (PSC), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Classic PSC
- PSC With Ulcerative Colitis
- PSC With Bile Duct Strictures
- 6.7. Global Cholestatic Pruritus Market, Sub-Segmentation Of Intrahepatic Cholestasis of Pregnancy (ICP), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Mild ICP
- Severe ICP
- ICP With Preterm Birth Risk
- 6.8. Global Cholestatic Pruritus Market, Sub-Segmentation Of Other Disease Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Alcoholic Cholestasis
- Drug-Induced Cholestasis
- Viral Hepatitis-Induced Cholestasis
- Genetic Cholestasis Disorders
7. Cholestatic Pruritus Market Regional And Country Analysis
- 7.1. Global Cholestatic Pruritus Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 7.2. Global Cholestatic Pruritus Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8. Asia-Pacific Cholestatic Pruritus Market
- 8.1. Asia-Pacific Cholestatic Pruritus Market Overview
- Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
- 8.2. Asia-Pacific Cholestatic Pruritus Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.3. Asia-Pacific Cholestatic Pruritus Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.4. Asia-Pacific Cholestatic Pruritus Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
9. China Cholestatic Pruritus Market
- 9.1. China Cholestatic Pruritus Market Overview
- 9.2. China Cholestatic Pruritus Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.3. China Cholestatic Pruritus Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.4. China Cholestatic Pruritus Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
10. India Cholestatic Pruritus Market
- 10.1. India Cholestatic Pruritus Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.2. India Cholestatic Pruritus Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.3. India Cholestatic Pruritus Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Japan Cholestatic Pruritus Market
- 11.1. Japan Cholestatic Pruritus Market Overview
- 11.2. Japan Cholestatic Pruritus Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.3. Japan Cholestatic Pruritus Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.4. Japan Cholestatic Pruritus Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. Australia Cholestatic Pruritus Market
- 12.1. Australia Cholestatic Pruritus Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.2. Australia Cholestatic Pruritus Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.3. Australia Cholestatic Pruritus Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13. Indonesia Cholestatic Pruritus Market
- 13.1. Indonesia Cholestatic Pruritus Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.2. Indonesia Cholestatic Pruritus Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.3. Indonesia Cholestatic Pruritus Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. South Korea Cholestatic Pruritus Market
- 14.1. South Korea Cholestatic Pruritus Market Overview
- 14.2. South Korea Cholestatic Pruritus Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.3. South Korea Cholestatic Pruritus Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.4. South Korea Cholestatic Pruritus Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Western Europe Cholestatic Pruritus Market
- 15.1. Western Europe Cholestatic Pruritus Market Overview
- 15.2. Western Europe Cholestatic Pruritus Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.3. Western Europe Cholestatic Pruritus Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.4. Western Europe Cholestatic Pruritus Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. UK Cholestatic Pruritus Market
- 16.1. UK Cholestatic Pruritus Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.2. UK Cholestatic Pruritus Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.3. UK Cholestatic Pruritus Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17. Germany Cholestatic Pruritus Market
- 17.1. Germany Cholestatic Pruritus Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.2. Germany Cholestatic Pruritus Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.3. Germany Cholestatic Pruritus Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18. France Cholestatic Pruritus Market
- 18.1. France Cholestatic Pruritus Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.2. France Cholestatic Pruritus Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.3. France Cholestatic Pruritus Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19. Italy Cholestatic Pruritus Market
- 19.1. Italy Cholestatic Pruritus Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.2. Italy Cholestatic Pruritus Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.3. Italy Cholestatic Pruritus Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20. Spain Cholestatic Pruritus Market
- 20.1. Spain Cholestatic Pruritus Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.2. Spain Cholestatic Pruritus Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.3. Spain Cholestatic Pruritus Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe Cholestatic Pruritus Market
- 21.1. Eastern Europe Cholestatic Pruritus Market Overview
- 21.2. Eastern Europe Cholestatic Pruritus Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.3. Eastern Europe Cholestatic Pruritus Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.4. Eastern Europe Cholestatic Pruritus Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. Russia Cholestatic Pruritus Market
- 22.1. Russia Cholestatic Pruritus Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.2. Russia Cholestatic Pruritus Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.3. Russia Cholestatic Pruritus Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. North America Cholestatic Pruritus Market
- 23.1. North America Cholestatic Pruritus Market Overview
- 23.2. North America Cholestatic Pruritus Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.3. North America Cholestatic Pruritus Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.4. North America Cholestatic Pruritus Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. USA Cholestatic Pruritus Market
- 24.1. USA Cholestatic Pruritus Market Overview
- 24.2. USA Cholestatic Pruritus Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.3. USA Cholestatic Pruritus Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.4. USA Cholestatic Pruritus Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25. Canada Cholestatic Pruritus Market
- 25.1. Canada Cholestatic Pruritus Market Overview
- 25.2. Canada Cholestatic Pruritus Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.3. Canada Cholestatic Pruritus Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.4. Canada Cholestatic Pruritus Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26. South America Cholestatic Pruritus Market
- 26.1. South America Cholestatic Pruritus Market Overview
- 26.2. South America Cholestatic Pruritus Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.3. South America Cholestatic Pruritus Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.4. South America Cholestatic Pruritus Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27. Brazil Cholestatic Pruritus Market
- 27.1. Brazil Cholestatic Pruritus Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.2. Brazil Cholestatic Pruritus Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.3. Brazil Cholestatic Pruritus Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28. Middle East Cholestatic Pruritus Market
- 28.1. Middle East Cholestatic Pruritus Market Overview
- 28.2. Middle East Cholestatic Pruritus Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.3. Middle East Cholestatic Pruritus Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.4. Middle East Cholestatic Pruritus Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29. Africa Cholestatic Pruritus Market
- 29.1. Africa Cholestatic Pruritus Market Overview
- 29.2. Africa Cholestatic Pruritus Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.3. Africa Cholestatic Pruritus Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.4. Africa Cholestatic Pruritus Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
30. Cholestatic Pruritus Market Competitive Landscape And Company Profiles
- 30.1. Cholestatic Pruritus Market Competitive Landscape
- 30.2. Cholestatic Pruritus Market Company Profiles
- 30.2.1. GlaxoSmithKline plc Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. Takeda Pharmaceutical Company Limited Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. Merck KGaA Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. Regeneron Pharmaceuticals Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. Bausch Health Companies Inc. Overview, Products and Services, Strategy and Financial Analysis
31. Cholestatic Pruritus Market Other Major And Innovative Companies
- 31.1. Incyte Corporation
- 31.2. Ipsen Pharma
- 31.3. Vanda Pharmaceuticals Inc.
- 31.4. Medison Pharma Ltd.
- 31.5. Mirum Pharmaceuticals Inc.
- 31.6. Albireo Pharma Inc.
- 31.7. Dipharma Francis S.r.l.
- 31.8. Cara Therapeutics Inc.
- 31.9. CANbridge Pharmaceuticals Inc.
- 31.10. Escient Pharmaceuticals Inc.
- 31.11. Tharimmune Inc.
- 31.12. Vifor Fresenius Medical Care Renal Pharma
- 31.13. CymaBay Therapeutics Inc.
- 31.14. ICE Pharma Inc.
- 31.15. Aquatic Remedies Private Limited
32. Global Cholestatic Pruritus Market Competitive Benchmarking And Dashboard
33. Key Mergers And Acquisitions In The Cholestatic Pruritus Market
34. Recent Developments In The Cholestatic Pruritus Market
35. Cholestatic Pruritus Market High Potential Countries, Segments and Strategies
- 35.1 Cholestatic Pruritus Market In 2029 - Countries Offering Most New Opportunities
- 35.2 Cholestatic Pruritus Market In 2029 - Segments Offering Most New Opportunities
- 35.3 Cholestatic Pruritus Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies
36. Appendix
- 36.1. Abbreviations
- 36.2. Currencies
- 36.3. Historic And Forecast Inflation Rates
- 36.4. Research Inquiries
- 36.5. The Business Research Company
- 36.6. Copyright And Disclaimer
